Breakdown | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | -118.49K | -121.79K | -109.46K | -110.32K |
EBITDA | -28.45M | -26.46M | -35.08M | -36.71M | -23.01M |
Net Income | -28.54M | -26.58M | -35.10M | -36.81M | -23.45M |
Balance Sheet | |||||
Total Assets | 128.11M | 149.12M | 169.50M | 198.17M | 80.58M |
Cash, Cash Equivalents and Short-Term Investments | 126.76M | 148.08M | 57.08M | 194.93M | 56.32M |
Total Debt | 329.26K | 80.33K | 209.83K | 330.97K | 59.09K |
Total Liabilities | 3.51M | 3.50M | 2.39M | 4.16M | 1.33M |
Stockholders Equity | 128.11M | 145.63M | 167.12M | 194.01M | 79.24M |
Cash Flow | |||||
Free Cash Flow | -22.72M | -19.78M | -28.70M | -25.42M | -16.98M |
Operating Cash Flow | -22.72M | -19.78M | -28.70M | -25.42M | -16.98M |
Investing Cash Flow | 91.79M | -3.53M | -52.35M | -35.01M | -21.74M |
Financing Cash Flow | 925.51K | -68.16K | 252.74K | 141.99M | 41.78M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
65 Neutral | ¥355.44B | 11.10 | -2.99% | 2.49% | 11.76% | -10.16% | |
52 Neutral | $105.82M | ― | -78.93% | ― | -70.15% | ― | |
46 Neutral | $83.01M | ― | -23.07% | ― | ― | -19.93% | |
45 Neutral | $166.57M | ― | -22.38% | ― | ― | ― | |
44 Neutral | $93.75M | ― | -55.14% | ― | -99.43% | -69.40% | |
44 Neutral | $55.78M | ― | -127.99% | ― | ― | 37.54% | |
28 Underperform | $58.86M | ― | -2355.27% | ― | -100.00% | 52.65% |
ESSA Pharma Inc. has introduced a new Severance Plan, replacing previous cash severance benefits for certain executive officers. This plan offers cash severance ranging from 1 to 1.5 times an officer’s base salary, with additional compensation for the CEO, tied to events like a Change in Control. The plan aims to retain key executives by providing economic security in case of qualifying terminations, ensuring stability and encouraging dedication to the company’s growth.